DSM Announces License Agreement with Amgen

News   Jan 15, 2013

 
DSM Announces License Agreement with Amgen
 
 
 

RELATED ARTICLES

New Drug Delivery System Targets Diseases at a Genetic Level

News

A new drug delivery system that uses a synthetic-biological hybrid nanocapsule could provide a smart technology for targeted treatment of a variety of serious diseases at the genetic level.

READ MORE

Mesenchymal Stem Cells can be Harvested from Amniotic Fluid During Caesareans

News

A team of scientists and clinicians at Lund University in Sweden have now developed a multi-step method, including a unique collection device and new cell harvesting and processing techniques, that enables term amniotic fluid to be safely harvested for large quantities of cells.

READ MORE

New Software Could Help Improve Cell-Authentication

News

Researchers at Columbia University and the New York Genome Center have developed a method to quickly and accurately identify people and cell lines from their DNA.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE